References
- Anderson A. B. M., Skolovsky E., Sayers L., Steele P. A., Turnbull A. C. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol. Br Med J 1978; 1: 140
- Borglin N. E., Staland B. Oral treatment of menopausal symptoms with natural oestrogens. Acta Obstet Gynecol Scand 1975, Suppl 43
- Edqvist L.-E., Johansson E. D. B. Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol 1972; 71: 716
- Englund D. E., Johansson E. D. B. Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women. Acta Obstet Gynecol Scand 1977; 27, Suppl 65
- Greenwald P., Caputo T. A., Wolfgang P. E. Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 1977; 50: 239
- Hutton J. D., Murray M. A. F., Jacobs H. S., James V. H. T. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1978; 1: 678
- Karonen S.-L., Lähteenmäki P., Hohenthal U., Adlercreutz H. Evaluation of the double antibody-solid phase radioimmunoassay technique in plasma LH and FSH and urinary LH measurements. Scand J Clin Lab Invest 1978; 38: 1
- Larsson-Cohn U., Johansson E. D. B., Kågedal B., Wallentin L. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynaecol 1978; 85: 367
- Martin P. L., Burnier A. M., Greaney M. O. Oral menopausal therapy using 17β-micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference. Obstet Gynecol 1972; 39: 771
- Yen S. S. C., Martin P. L., Burnier A. M., Czekala N. M., Greaney M. O., Jr., Callantine M. R. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1975; 40: 518